Search details
1.
Recommendations for reporting tissue and circulating tumour (ct)DNA next-generation sequencing results in non-small cell lung cancer.
Br J Cancer
; 2024 May 15.
Article
in English
| MEDLINE | ID: mdl-38750115
2.
Olaparib maintenance versus placebo in platinum-sensitive non-small cell lung cancer: the Phase 2 randomized PIPSeN trial.
Br J Cancer
; 130(3): 417-424, 2024 02.
Article
in English
| MEDLINE | ID: mdl-38097741
3.
Integration of Data and Predictive Models for the Evaluation of Air Quality and Noise in Urban Environments.
Sensors (Basel)
; 24(2)2024 Jan 05.
Article
in English
| MEDLINE | ID: mdl-38257404
4.
Tepotinib in Non-Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations.
N Engl J Med
; 383(10): 931-943, 2020 09 03.
Article
in English
| MEDLINE | ID: mdl-32469185
5.
Plain language summary of the development of tepotinib: a treatment for a subtype of non-small cell lung cancer called MET exon 14 skipping.
Future Oncol
; 19(10): 683-696, 2023 Mar.
Article
in English
| MEDLINE | ID: mdl-36999526
6.
Neoadjuvant chemotherapy and nivolumab in resectable non-small-cell lung cancer (NADIM): an open-label, multicentre, single-arm, phase 2 trial.
Lancet Oncol
; 21(11): 1413-1422, 2020 11.
Article
in English
| MEDLINE | ID: mdl-32979984
7.
A phase Ib study of GSK3052230, an FGF ligand trap in combination with pemetrexed and cisplatin in patients with malignant pleural mesothelioma.
Invest New Drugs
; 38(2): 457-467, 2020 04.
Article
in English
| MEDLINE | ID: mdl-31065954
8.
Identification of ALK, ROS1, and RET Fusions by a Multiplexed mRNA-Based Assay in Formalin-Fixed, Paraffin-Embedded Samples from Advanced Non-Small-Cell Lung Cancer Patients.
Clin Chem
; 63(3): 751-760, 2017 03.
Article
in English
| MEDLINE | ID: mdl-28073897
9.
Phase I, dose-escalating study of elisidepsin (Irvalec(®)), a plasma membrane-disrupting marine antitumor agent, in combination with erlotinib in patients with advanced malignant solid tumors.
Invest New Drugs
; 34(1): 75-83, 2016 Feb.
Article
in English
| MEDLINE | ID: mdl-26627080
10.
COVID-19 in melanoma patients: Results of the Spanish Melanoma Group Registry, GRAVID study.
J Am Acad Dermatol
; 84(5): 1412-1415, 2021 05.
Article
in English
| MEDLINE | ID: mdl-33581187
11.
Frequency, underdiagnosis, and heterogeneity of epidermal growth factor receptor exon 20 insertion mutations using real-world genomic datasets.
Mol Oncol
; 17(2): 230-237, 2023 02.
Article
in English
| MEDLINE | ID: mdl-36269676
12.
ONCOS-102 plus pemetrexed and platinum chemotherapy in malignant pleural mesothelioma: a randomized phase 2 study investigating clinical outcomes and the tumor microenvironment.
J Immunother Cancer
; 11(9)2023 09.
Article
in English
| MEDLINE | ID: mdl-37661097
13.
Detecting ALK, ROS1, and RET fusions and the METΔex14 splicing variant in liquid biopsies of non-small-cell lung cancer patients using RNA-based techniques.
Mol Oncol
; 17(9): 1884-1897, 2023 09.
Article
in English
| MEDLINE | ID: mdl-37243883
14.
An Adjusted Treatment Comparison Comparing Amivantamab Versus Real-World Clinical Practice in Europe and the United States for Patients with Advanced Non-Small Cell Lung Cancer with Activating Epidermal Growth Factor Receptor Exon 20 Insertion Mutations.
Adv Ther
; 40(3): 1187-1203, 2023 03.
Article
in English
| MEDLINE | ID: mdl-36652175
15.
Tepotinib in patients with non-small cell lung cancer with high-level MET amplification detected by liquid biopsy: VISION Cohort B.
Cell Rep Med
; 4(11): 101280, 2023 11 21.
Article
in English
| MEDLINE | ID: mdl-37944528
16.
Tepotinib Treatment in Patients With MET Exon 14-Skipping Non-Small Cell Lung Cancer: Long-term Follow-up of the VISION Phase 2 Nonrandomized Clinical Trial.
JAMA Oncol
; 9(9): 1260-1266, 2023 09 01.
Article
in English
| MEDLINE | ID: mdl-37270698
17.
Cabozantinib for the treatment of solid tumors: a systematic review.
Ther Adv Med Oncol
; 14: 17588359221107112, 2022.
Article
in English
| MEDLINE | ID: mdl-35847482
18.
Cabozantinib combination therapy for the treatment of solid tumors: a systematic review.
Ther Adv Med Oncol
; 14: 17588359221108691, 2022.
Article
in English
| MEDLINE | ID: mdl-35923927
19.
Comparative Clinical Outcomes Between EGFR Ex20ins and Wildtype NSCLC Treated with Immune Checkpoint Inhibitors.
Clin Lung Cancer
; 23(7): 571-577, 2022 11.
Article
in English
| MEDLINE | ID: mdl-36085282
20.
Safety of MET Tyrosine Kinase Inhibitors in Patients With MET Exon 14 Skipping Non-small Cell Lung Cancer: A Clinical Review.
Clin Lung Cancer
; 23(3): 195-207, 2022 05.
Article
in English
| MEDLINE | ID: mdl-35272955